Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

This study has been completed.
Sponsor:
Collaborators:
Population Health Research Institute
Uppsala University
Information provided by:
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT00262600
First received: December 6, 2005
Last updated: April 25, 2014
Last verified: April 2014
  Purpose

The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism.


Condition Intervention Phase
Atrial Fibrillation
Stroke
Drug: warfarin
Drug: Dabigatran dose 1
Drug: Dabigatran dose 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Prevention
Official Title: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate With Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation: Prospective, Multi-centre, Parallel-group, Non-inferiority Trial (RE-LY Study)

Resource links provided by NLM:


Further study details as provided by Boehringer Ingelheim:

Primary Outcome Measures:
  • Yearly Event Rate for Composite Endpoint of Stroke/SEE [ Time Frame: 36 months ] [ Designated as safety issue: No ]
    Time to first occurrence of stroke or systemic embolic event. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25


Secondary Outcome Measures:
  • Yearly Event Rate for Composite Endpoint of Stroke/SEE/All Cause Death [ Time Frame: 36 months ] [ Designated as safety issue: No ]
    Time to first occurrence of stroke, SEE or all cause death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25

  • Yearly Event Rate: Composite of Stroke/SEE/PE/MI/Vascular Death [ Time Frame: 36 months ] [ Designated as safety issue: No ]
    Time to first occurrence of stroke, systemic embolic event, pulmonary embolism, myocardial infarction including silent myocardial infarction or vascular death. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25

  • Bleeding Events (Major and Minor) [ Time Frame: 36 months ] [ Designated as safety issue: Yes ]

    Yearly event rate of bleeds. Yearly event rate (%) = number of subjects with event / subject-years * 100. Subject years = sum(date of study termination - date of randomization + 1) of all randomized subjects / 365.25

    Major bleeds are adjudicated, whereas minor bleeds are investigator reported.


  • Clinical Relevant Abnormalities for Intracerebral Hemorrhage and Other Intracranial Hemorrhage (ICH) [ Time Frame: 36 months ] [ Designated as safety issue: No ]
    Patients with clinical relevant abnormalities for intracerebral hemorrhage, other intracranial hemorrhage (ICH)

  • Abnormal Liver Function Test [ Time Frame: 36 months ] [ Designated as safety issue: No ]
    Number of subjects with abnormal liver function test (LFT), i.e., ALT/AST>3xULN and total bilirubin > 2 x ULN


Enrollment: 18113
Study Start Date: November 2005
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Dabigatran dose 2
twice a day
Drug: Dabigatran dose 2
twice a day
Active Comparator: Warfarin
once a day
Drug: warfarin
once a day
Active Comparator: Dabigatran dose 1
twice a day
Drug: Dabigatran dose 1
twice daily

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria Patients with non-valvular atrial fibrillation (AF), at moderate to high risk of stroke, or systemic embolism with at least one additional risk factor (i.e. previous ischemic stroke, TIA, or systemic embolism, left ventricular dysfunction, age >=75 years, age >=65 with either diabetes mellitus, history of coronary artery disease or hypertension)

Exclusion criteria

  1. Prosthetic heart valves requiring anticoagulation per se, or hemodynamically relevant valve disease that is expected to require surgical intervention during the course of the study
  2. Severe, disabling stroke within the previous 6 months, or any stroke within the previous 14 days
  3. Conditions associated with an increased risk of bleeding
  4. Contraindication to warfarin treatment
  5. Reversible causes of atrial fibrillation (e.g., cardiac surgery, pulmonary embolism, untreated hyperthyroidism).
  6. Plan to perform a pulmonary vein ablation or surgery for cure of the AF
  7. Severe renal impairment (estimated creatinine clearance <=30 mL/min)
  8. Active infective endocarditis
  9. Active liver disease
  10. Women who are pregnant, lactating, or of childbearing potential who refuse to use a medically acceptable form of contraception throughout the study
  11. Anaemia (haemoglobin <100g/L) or thrombocytopenia (platelet count <100 x 109/L)
  12. Patients who have developed transaminase elevations upon exposure to ximelagatran
  13. Patients who have received an investigational drug in the past 30 days or are participating in another drug study
  14. Patients considered unreliable by the investigator concerning the requirements for follow-up during the study and/or compliance with study drug administration, has a life expectancy less than the expected duration of the trial due to concomitant disease, or has any condition which in the opinion of the investigator, would not allow safe participation in the study (e.g., drug addiction, alcohol abuse)
  15. Any known hypersensitivity to galactose if the warfarin used contains galactose.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00262600

  Hide Study Locations
Locations
United States, Alabama
1160.26.0046 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
1160.26.0057 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
1160.26.0009 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
1160.26.0211 Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
1160.26.0206 Boehringer Ingelheim Investigational Site
Huntsville, Alabama, United States
1160.26.0115 Boehringer Ingelheim Investigational Site
Mobile, Alabama, United States
United States, Arizona
1160.26.0104 Boehringer Ingelheim Investigational Site
Lake Havasu City, Arizona, United States
1160.26.0304 Boehringer Ingelheim Investigational Site
Peoria, Arizona, United States
1160.26.0305 Boehringer Ingelheim Investigational Site
Tucson, Arizona, United States
1160.26.0185 Boehringer Ingelheim Investigational Site
Tucson, Arizona, United States
United States, Arkansas
1160.26.0038 Boehringer Ingelheim Investigational Site
Hot Springs, Arkansas, United States
1160.26.0302 Boehringer Ingelheim Investigational Site
Jonesboro, Arkansas, United States
1160.26.0191 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
1160.26.0455 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
1160.26.0213 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
1160.26.0121 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
1160.26.0204 Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
United States, California
1160.26.0388 Boehringer Ingelheim Investigational Site
Anaheim, California, United States
1160.26.0441 Boehringer Ingelheim Investigational Site
Carmichael, California, United States
1160.26.0145 Boehringer Ingelheim Investigational Site
French Camp, California, United States
1160.26.0333 Boehringer Ingelheim Investigational Site
Fullerton, California, United States
1160.26.0384 Boehringer Ingelheim Investigational Site
La Jolla, California, United States
1160.26.0091 Boehringer Ingelheim Investigational Site
LaMesa, California, United States
1160.26.0246 Boehringer Ingelheim Investigational Site
Lancaster, California, United States
1160.26.0345 Boehringer Ingelheim Investigational Site
Larkspur, California, United States
1160.26.0217 Boehringer Ingelheim Investigational Site
Loma Linda, California, United States
1160.26.0059 Boehringer Ingelheim Investigational Site
Los Angeles, California, United States
1160.26.0088 Boehringer Ingelheim Investigational Site
Los Angeles, California, United States
1160.26.0337 Boehringer Ingelheim Investigational Site
Los Angeles, California, United States
1160.26.0326 Boehringer Ingelheim Investigational Site
Mather, California, United States
1160.26.0070 Boehringer Ingelheim Investigational Site
Merced, California, United States
1160.26.0349 Boehringer Ingelheim Investigational Site
Oakland, California, United States
1160.26.0016 Boehringer Ingelheim Investigational Site
Oceanside, California, United States
1160.26.0087 Boehringer Ingelheim Investigational Site
Palm Springs, California, United States
1160.26.0459 Boehringer Ingelheim Investigational Site
Pasadena, California, United States
1160.26.0216 Boehringer Ingelheim Investigational Site
Redondo Beach, California, United States
1160.26.0135 Boehringer Ingelheim Investigational Site
Riverside, California, United States
1160.26.0162 Boehringer Ingelheim Investigational Site
Sacramento, California, United States
1160.26.0300 Boehringer Ingelheim Investigational Site
Sacramento, California, United States
1160.26.0371 Boehringer Ingelheim Investigational Site
Sacramento, California, United States
1160.26.0270 Boehringer Ingelheim Investigational Site
San Diego, California, United States
1160.26.0148 Boehringer Ingelheim Investigational Site
San Diego, California, United States
1160.26.0284 Boehringer Ingelheim Investigational Site
San Diego, California, United States
1160.26.0116 Boehringer Ingelheim Investigational Site
San Diego, California, United States
1160.26.0351 Boehringer Ingelheim Investigational Site
Santa Ana, California, United States
1160.26.0043 Boehringer Ingelheim Investigational Site
Santa Rosa, California, United States
1160.26.0462 Boehringer Ingelheim Investigational Site
Sylmar, California, United States
1160.26.0276 Boehringer Ingelheim Investigational Site
Torrance, California, United States
1160.26.0379 Boehringer Ingelheim Investigational Site
Walnut Creek, California, United States
United States, Colorado
1160.26.0419 Boehringer Ingelheim Investigational Site
Aurora, Colorado, United States
1160.26.0449 Boehringer Ingelheim Investigational Site
Colorado Springs, Colorado, United States
1160.26.0321 Boehringer Ingelheim Investigational Site
Colorado Springs, Colorado, United States
1160.26.0413 Boehringer Ingelheim Investigational Site
Denver, Colorado, United States
1160.26.0360 Boehringer Ingelheim Investigational Site
Denver, Colorado, United States
1160.26.0362 Boehringer Ingelheim Investigational Site
Fort Collins, Colorado, United States
1160.26.0399 Boehringer Ingelheim Investigational Site
Greeley, Colorado, United States
United States, Connecticut
1160.26.0058 Boehringer Ingelheim Investigational Site
Bridgeport, Connecticut, United States
1160.26.0278 Boehringer Ingelheim Investigational Site
Bridgeport, Connecticut, United States
1160.26.0241 Boehringer Ingelheim Investigational Site
Bridgeport, Connecticut, United States
1160.26.0085 Boehringer Ingelheim Investigational Site
Fairfield, Connecticut, United States
1160.26.0482 Boehringer Ingelheim Investigational Site
Guilford, Connecticut, United States
United States, Delaware
1160.26.0366 Boehringer Ingelheim Investigational Site
Newark, Delaware, United States
United States, District of Columbia
1160.26.0343 Boehringer Ingelheim Investigational Site
Washington, District of Columbia, United States
United States, Florida
1160.26.0022 Boehringer Ingelheim Investigational Site
Atlantis, Florida, United States
1160.26.0382 Boehringer Ingelheim Investigational Site
Boynton Beach, Florida, United States
1160.26.0056 Boehringer Ingelheim Investigational Site
Brandon, Florida, United States
1160.26.0429 Boehringer Ingelheim Investigational Site
Clearwater, Florida, United States
1160.26.0296 Boehringer Ingelheim Investigational Site
Clearwater, Florida, United States
1160.26.0105 Boehringer Ingelheim Investigational Site
Clearwater, Florida, United States
1160.26.0376 Boehringer Ingelheim Investigational Site
Daytona Beach, Florida, United States
1160.26.0411 Boehringer Ingelheim Investigational Site
Deerfield Beach, Florida, United States
1160.26.0074 Boehringer Ingelheim Investigational Site
Fort Meyers, Florida, United States
1160.26.0239 Boehringer Ingelheim Investigational Site
Gainsville, Florida, United States
1160.26.0260 Boehringer Ingelheim Investigational Site
Hollywood, Florida, United States
1160.26.0265 Boehringer Ingelheim Investigational Site
Hollywood, Florida, United States
1160.26.0100 Boehringer Ingelheim Investigational Site
Inverness, Florida, United States
1160.26.0033 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
1160.26.0427 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
1160.26.0089 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
1160.26.0232 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
1160.26.0240 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
1160.26.0464 Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
1160.26.0209 Boehringer Ingelheim Investigational Site
Jacksonville Beach, Florida, United States
1160.26.0012 Boehringer Ingelheim Investigational Site
Lakeland, Florida, United States
1160.26.0259 Boehringer Ingelheim Investigational Site
Melbourne, Florida, United States
1160.26.0358 Boehringer Ingelheim Investigational Site
Melbourne, Florida, United States
1160.26.0034 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
1160.26.0199 Boehringer Ingelheim Investigational Site
Miami, Florida, United States
1160.26.0227 Boehringer Ingelheim Investigational Site
Orlando, Florida, United States
1160.26.0095 Boehringer Ingelheim Investigational Site
Ormond Beach, Florida, United States
1160.26.0037 Boehringer Ingelheim Investigational Site
Pensacola, Florida, United States
1160.26.0076 Boehringer Ingelheim Investigational Site
Pensacola, Florida, United States
1160.26.0111 Boehringer Ingelheim Investigational Site
Pensacola, Florida, United States
1160.26.0081 Boehringer Ingelheim Investigational Site
Pensacola, Florida, United States
1160.26.0137 Boehringer Ingelheim Investigational Site
Port Charlotte, Florida, United States
1160.26.0417 Boehringer Ingelheim Investigational Site
Port Charlotte, Florida, United States
1160.26.0389 Boehringer Ingelheim Investigational Site
Port Charlotte, Florida, United States
1160.26.0332 Boehringer Ingelheim Investigational Site
Rockledge, Florida, United States
1160.26.0226 Boehringer Ingelheim Investigational Site
Safety Harbor, Florida, United States
1160.26.0031 Boehringer Ingelheim Investigational Site
Sarasota, Florida, United States
1160.26.0385 Boehringer Ingelheim Investigational Site
Sarasota, Florida, United States
1160.26.0339 Boehringer Ingelheim Investigational Site
St. Petersburg, Florida, United States
1160.26.0015 Boehringer Ingelheim Investigational Site
St. Petersburg, Florida, United States
1160.26.0010 Boehringer Ingelheim Investigational Site
Stuart, Florida, United States
1160.26.0327 Boehringer Ingelheim Investigational Site
Tamarac, Florida, United States
1160.26.0381 Boehringer Ingelheim Investigational Site
Tampa, Florida, United States
1160.26.0271 Boehringer Ingelheim Investigational Site
Tampa, Florida, United States
1160.26.0328 Boehringer Ingelheim Investigational Site
Tampa, Florida, United States
1160.26.0019 Boehringer Ingelheim Investigational Site
Vero Beach, Florida, United States
United States, Georgia
1160.26.0283 Boehringer Ingelheim Investigational Site
Atlanta, Georgia, United States
1160.26.0338 Boehringer Ingelheim Investigational Site
Atlanta, Georgia, United States
1160.26.0159 Boehringer Ingelheim Investigational Site
Atlanta, Georgia, United States
1160.26.0021 Boehringer Ingelheim Investigational Site
Augusta, Georgia, United States
1160.26.0319 Boehringer Ingelheim Investigational Site
Augusta, Georgia, United States
1160.26.0092 Boehringer Ingelheim Investigational Site
Blue Ridge, Georgia, United States
1160.26.0161 Boehringer Ingelheim Investigational Site
Conyers, Georgia, United States
United States, Idaho
1160.26.0026 Boehringer Ingelheim Investigational Site
Couer d'Alene, Idaho, United States
United States, Illinois
1160.26.0218 Boehringer Ingelheim Investigational Site
Berwyn, Illinois, United States
1160.26.0457 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.26.0324 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.26.0184 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.26.0233 Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
1160.26.0237 Boehringer Ingelheim Investigational Site
Evanston, Illinois, United States
1160.26.0236 Boehringer Ingelheim Investigational Site
Glenview, Illinois, United States
1160.26.0396 Boehringer Ingelheim Investigational Site
Hines, Illinois, United States
1160.26.0438 Boehringer Ingelheim Investigational Site
Maywood, Illinois, United States
1160.26.0331 Boehringer Ingelheim Investigational Site
Melrose Park, Illinois, United States
1160.26.0364 Boehringer Ingelheim Investigational Site
Normal, Illinois, United States
1160.26.0109 Boehringer Ingelheim Investigational Site
North Chicago, Illinois, United States
1160.26.0152 Boehringer Ingelheim Investigational Site
Oak Lawn, Illinois, United States
1160.26.0198 Boehringer Ingelheim Investigational Site
Rockford, Illinois, United States
1160.26.0433 Boehringer Ingelheim Investigational Site
Winfield, Illinois, United States
United States, Indiana
1160.26.0041 Boehringer Ingelheim Investigational Site
Evansville, Indiana, United States
1160.26.0377 Boehringer Ingelheim Investigational Site
Fort Wayne, Indiana, United States
1160.26.0436 Boehringer Ingelheim Investigational Site
Indianapolis, Indiana, United States
1160.26.0288 Boehringer Ingelheim Investigational Site
Indianapolis, Indiana, United States
1160.26.0352 Boehringer Ingelheim Investigational Site
Indinapolis, Indiana, United States
1160.26.0028 Boehringer Ingelheim Investigational Site
Jeffersonville, Indiana, United States
1160.26.0235 Boehringer Ingelheim Investigational Site
South Bend, Indiana, United States
United States, Iowa
1160.26.0268 Boehringer Ingelheim Investigational Site
Dubuque, Iowa, United States
1160.26.0189 Boehringer Ingelheim Investigational Site
West Des Moines, Iowa, United States
1160.26.0357 Boehringer Ingelheim Investigational Site
West Des Moines, Iowa, United States
1160.26.0001 Boehringer Ingelheim Investigational Site
West Des Moines, Iowa, United States
United States, Kansas
1160.26.0354 Boehringer Ingelheim Investigational Site
Wichita, Kansas, United States
United States, Kentucky
1160.26.0077 Boehringer Ingelheim Investigational Site
Bowling Green, Kentucky, United States
1160.26.0138 Boehringer Ingelheim Investigational Site
Crestview Hills, Kentucky, United States
1160.26.0422 Boehringer Ingelheim Investigational Site
Lexington, Kentucky, United States
1160.26.0397 Boehringer Ingelheim Investigational Site
Louisville, Kentucky, United States
1160.26.0178 Boehringer Ingelheim Investigational Site
Louisville, Kentucky, United States
1160.26.0310 Boehringer Ingelheim Investigational Site
Owensboro, Kentucky, United States
United States, Louisiana
1160.26.0144 Boehringer Ingelheim Investigational Site
Baton Rouge, Louisiana, United States
1160.26.0404 Boehringer Ingelheim Investigational Site
Baton Rouge, Louisiana, United States
1160.26.0011 Boehringer Ingelheim Investigational Site
Baton Rouge, Louisiana, United States
1160.26.0093 Boehringer Ingelheim Investigational Site
Covington, Louisiana, United States
1160.26.0340 Boehringer Ingelheim Investigational Site
LaCombe, Louisiana, United States
1160.26.0391 Boehringer Ingelheim Investigational Site
Lafayette, Louisiana, United States
1160.26.0018 Boehringer Ingelheim Investigational Site
Lafayette, Louisiana, United States
1160.26.0252 Boehringer Ingelheim Investigational Site
Morgan City, Louisiana, United States
1160.26.0132 Boehringer Ingelheim Investigational Site
New Iberia, Louisiana, United States
1160.26.0299 Tulane University School Of Medicine
New Orleans, Louisiana, United States
1160.26.0048 Boehringer Ingelheim Investigational Site
Shrevport, Louisiana, United States
United States, Maine
1160.26.0096 Boehringer Ingelheim Investigational Site
Auburn, Maine, United States
1160.26.0068 Boehringer Ingelheim Investigational Site
Scarborough, Maine, United States
United States, Maryland
1160.26.0114 Boehringer Ingelheim Investigational Site
Annapolis, Maryland, United States
1160.26.0164 Boehringer Ingelheim Investigational Site
Annapolis, Maryland, United States
1160.26.0186 Boehringer Ingelheim Investigational Site
Baltimore, Maryland, United States
1160.26.0023 Boehringer Ingelheim Investigational Site
Baltimore, Maryland, United States
1160.26.0079 Boehringer Ingelheim Investigational Site
Baltimore, Maryland, United States
1160.26.0047 Boehringer Ingelheim Investigational Site
Baltimore, Maryland, United States
1160.26.0194 Boehringer Ingelheim Investigational Site
Baltimore, Maryland, United States
1160.26.0255 Boehringer Ingelheim Investigational Site
Bel Air, Maryland, United States
1160.26.0398 Boehringer Ingelheim Investigational Site
Columbia, Maryland, United States
1160.26.0177 Boehringer Ingelheim Investigational Site
Rockville, Maryland, United States
1160.26.0073 Boehringer Ingelheim Investigational Site
Salisbury, Maryland, United States
1160.26.0207 Boehringer Ingelheim Investigational Site
Salisbury, Maryland, United States
1160.26.0196 Boehringer Ingelheim Investigational Site
Takoma Park, Maryland, United States
1160.26.0187 Boehringer Ingelheim Investigational Site
Towson, Maryland, United States
1160.26.0052 Boehringer Ingelheim Investigational Site
Westminster, Maryland, United States
United States, Massachusetts
1160.26.0042 Boehringer Ingelheim Investigational Site
Ayer, Massachusetts, United States
1160.26.0401 Boehringer Ingelheim Investigational Site
Boston, Massachusetts, United States
1160.26.0160 Boehringer Ingelheim Investigational Site
East Bridgewater, Massachusetts, United States
1160.26.0452 Boehringer Ingelheim Investigational Site
Haverhill, Massachusetts, United States
1160.26.0443 Boehringer Ingelheim Investigational Site
Haverhill, Massachusetts, United States
1160.26.0029 Boehringer Ingelheim Investigational Site
Natick, Massachusetts, United States
1160.26.0446 Boehringer Ingelheim Investigational Site
Newtown, Massachusetts, United States
1160.26.0003 Boehringer Ingelheim Investigational Site
North Dartmouth, Massachusetts, United States
1160.26.0470 Boehringer Ingelheim Investigational Site
Northborough, Massachusetts, United States
1160.26.0308 Boehringer Ingelheim Investigational Site
Worcester, Massachusetts, United States
United States, Michigan
1160.26.0141 Boehringer Ingelheim Investigational Site
Bloomfield Hills, Michigan, United States
1160.26.0225 Boehringer Ingelheim Investigational Site
Detroit, Michigan, United States
1160.26.0154 Boehringer Ingelheim Investigational Site
Grand Blanc, Michigan, United States
1160.26.0030 Boehringer Ingelheim Investigational Site
Grand Rapids, Michigan, United States
1160.26.0171 Boehringer Ingelheim Investigational Site
Kalamazoo, Michigan, United States
1160.26.0205 Boehringer Ingelheim Investigational Site
Lapeer, Michigan, United States
1160.26.0279 Boehringer Ingelheim Investigational Site
Muskegon, Michigan, United States
1160.26.0445 Boehringer Ingelheim Investigational Site
Petoskey, Michigan, United States
1160.26.0274 Boehringer Ingelheim Investigational Site
Rochester Hills, Michigan, United States
1160.26.0165 Boehringer Ingelheim Investigational Site
Saginaw, Michigan, United States
1160.26.0020 Boehringer Ingelheim Investigational Site
Troy, Michigan, United States
1160.26.0188 Boehringer Ingelheim Investigational Site
Ypsilanti, Michigan, United States
United States, Minnesota
1160.26.0131 Boehringer Ingelheim Investigational Site
Minneapolis, Minnesota, United States
1160.26.0421 Boehringer Ingelheim Investigational Site
Minneapolis, Minnesota, United States
1160.26.0202 Boehringer Ingelheim Investigational Site
Robbinsondale, Minnesota, United States
1160.26.0101 Boehringer Ingelheim Investigational Site
St. Paul, Minnesota, United States
United States, Mississippi
1160.26.0086 Boehringer Ingelheim Investigational Site
Gulfport, Mississippi, United States
1160.26.0119 Boehringer Ingelheim Investigational Site
Tupelo, Mississippi, United States
United States, Missouri
1160.26.0055 Boehringer Ingelheim Investigational Site
Columbia, Missouri, United States
1160.26.0172 Boehringer Ingelheim Investigational Site
Columbia, Missouri, United States
1160.26.0257 Boehringer Ingelheim Investigational Site
Kansas City, Missouri, United States
1160.26.0266 Boehringer Ingelheim Investigational Site
Kansas City, Missouri, United States
1160.26.0336 Boehringer Ingelheim Investigational Site
St. Charles, Missouri, United States
1160.26.0249 Boehringer Ingelheim Investigational Site
St. Louis, Missouri, United States
United States, Montana
1160.26.0027 Boehringer Ingelheim Investigational Site
Kalispell, Montana, United States
United States, Nebraska
1160.26.0128 Boehringer Ingelheim Investigational Site
Alliance, Nebraska, United States
1160.26.0110 Boehringer Ingelheim Investigational Site
Omaha, Nebraska, United States
1160.26.0355 Boehringer Ingelheim Investigational Site
Papillion, Nebraska, United States
United States, Nevada
1160.26.0346 Boehringer Ingelheim Investigational Site
Henderson, Nevada, United States
1160.26.0174 Boehringer Ingelheim Investigational Site
Las Vegas, Nevada, United States
1160.26.0066 Boehringer Ingelheim Investigational Site
Las Vegas, Nevada, United States
1160.26.0430 Boehringer Ingelheim Investigational Site
Las Vegas, Nevada, United States
United States, New Hampshire
1160.26.0190 Boehringer Ingelheim Investigational Site
Lebanon, New Hampshire, United States
United States, New Jersey
1160.26.0142 Boehringer Ingelheim Investigational Site
Browns Mills, New Jersey, United States
1160.26.0125 Boehringer Ingelheim Investigational Site
Cherry Hill, New Jersey, United States
1160.26.0432 Boehringer Ingelheim Investigational Site
Elmer, New Jersey, United States
1160.26.0448 Boehringer Ingelheim Investigational Site
Englewood, New Jersey, United States
1160.26.0248 Boehringer Ingelheim Investigational Site
Flemington, New Jersey, United States
1160.26.0244 Boehringer Ingelheim Investigational Site
Haddon Heights, New Jersey, United States
1160.26.0243 Boehringer Ingelheim Investigational Site
New Brunswick, New Jersey, United States
1160.26.0478 Boehringer Ingelheim Investigational Site
Oakland, New Jersey, United States
1160.26.0392 Boehringer Ingelheim Investigational Site
Ocean, New Jersey, United States
1160.26.0472 Boehringer Ingelheim Investigational Site
Paterson, New Jersey, United States
1160.26.0221 Boehringer Ingelheim Investigational Site
Voorhees, New Jersey, United States
1160.26.0254 Boehringer Ingelheim Investigational Site
Westwood, New Jersey, United States
United States, New Mexico
1160.26.0127 Boehringer Ingelheim Investigational Site
Albuquerque, New Mexico, United States
1160.26.0423 Boehringer Ingelheim Investigational Site
Albuquerque, New Mexico, United States
United States, New York
1160.26.0476 Boehringer Ingelheim Investigational Site
Albany, New York, United States
1160.26.0281 Boehringer Ingelheim Investigational Site
Bronx, New York, United States
1160.26.0113 Boehringer Ingelheim Investigational Site
Bronx, New York, United States
1160.26.0063 Boehringer Ingelheim Investigational Site
Buffalo, New York, United States
1160.26.0044 Boehringer Ingelheim Investigational Site
Cortlandt Manor, New York, United States
1160.26.0373 Boehringer Ingelheim Investigational Site
Flushing, New York, United States
1160.26.0045 Boehringer Ingelheim Investigational Site
Garden City, New York, United States
1160.26.0251 Boehringer Ingelheim Investigational Site
Kingston, New York, United States
1160.26.0451 Boehringer Ingelheim Investigational Site
Mineola, New York, United States
1160.26.0229 Boehringer Ingelheim Investigational Site
Mineola, New York, United States
1160.26.0090 Boehringer Ingelheim Investigational Site
New Hyde Park, New York, United States
1160.26.0183 Boehringer Ingelheim Investigational Site
New Rochelle, New York, United States
1160.26.0316 Boehringer Ingelheim Investigational Site
New York, New York, United States
1160.26.0146 Boehringer Ingelheim Investigational Site
North Massapequa, New York, United States
1160.26.0210 Boehringer Ingelheim Investigational Site
Northport, New York, United States
1160.26.0075 Boehringer Ingelheim Investigational Site
Poughkeepsie, New York, United States
1160.26.0197 Boehringer Ingelheim Investigational Site
Rochester, New York, United States
1160.26.0320 Boehringer Ingelheim Investigational Site
Rochester, New York, United States
1160.26.0064 Boehringer Ingelheim Investigational Site
Scarsdale, New York, United States
1160.26.0414 Boehringer Ingelheim Investigational Site
Troy, New York, United States
1160.26.0356 Boehringer Ingelheim Investigational Site
Watertown, New York, United States
1160.26.0039 Boehringer Ingelheim Investigational Site
Williamsville, New York, United States
United States, North Carolina
1160.26.0353 Boehringer Ingelheim Investigational Site
Asheville, North Carolina, United States
1160.26.0080 Boehringer Ingelheim Investigational Site
Charlotte, North Carolina, United States
1160.26.0412 Boehringer Ingelheim Investigational Site
Charlotte, North Carolina, United States
1160.26.0350 Boehringer Ingelheim Investigational Site
Gastonia, North Carolina, United States
1160.26.0322 Boehringer Ingelheim Investigational Site
Greensboro, North Carolina, United States
1160.26.0173 Boehringer Ingelheim Investigational Site
High Point, North Carolina, United States
1160.26.0108 Boehringer Ingelheim Investigational Site
Lexington, North Carolina, United States
1160.26.0006 Boehringer Ingelheim Investigational Site
Pinehurst, North Carolina, United States
1160.26.0002 Boehringer Ingelheim Investigational Site
Statesville, North Carolina, United States
1160.26.0069 Boehringer Ingelheim Investigational Site
Statesville, North Carolina, United States
1160.26.0372 Boehringer Ingelheim Investigational Site
Wilmington, North Carolina, United States
1160.26.0425 Boehringer Ingelheim Investigational Site
Winston Salem, North Carolina, United States
1160.26.0094 Boehringer Ingelheim Investigational Site
Winston Salem, North Carolina, United States
United States, North Dakota
1160.26.0102 Boehringer Ingelheim Investigational Site
Grand Forks, North Dakota, United States
1160.26.0222 Boehringer Ingelheim Investigational Site
Jamestown, North Dakota, United States
United States, Ohio
1160.26.0203 Boehringer Ingelheim Investigational Site
Akron, Ohio, United States
1160.26.0434 Boehringer Ingelheim Investigational Site
Canal Fulton, Ohio, United States
1160.26.0426 Boehringer Ingelheim Investigational Site
Cincinnati, Ohio, United States
1160.26.0083 Boehringer Ingelheim Investigational Site
Cincinnati, Ohio, United States
1160.26.0402 Boehringer Ingelheim Investigational Site
Cincinnati, Ohio, United States
1160.26.0479 Boehringer Ingelheim Investigational Site
Cincinnati, Ohio, United States
1160.26.0480 Boehringer Ingelheim Investigational Site
Cleveland, Ohio, United States
1160.26.0263 Boehringer Ingelheim Investigational Site
Cleveland, Ohio, United States
1160.26.0267 Boehringer Ingelheim Investigational Site
Columbus, Ohio, United States
1160.26.0035 Boehringer Ingelheim Investigational Site
Dayton, Ohio, United States
1160.26.0150 Boehringer Ingelheim Investigational Site
Fairview Park, Ohio, United States
1160.26.0201 Boehringer Ingelheim Investigational Site
Kettering, Ohio, United States
1160.26.0223 Boehringer Ingelheim Investigational Site
Lorain, Ohio, United States
1160.26.0214 Boehringer Ingelheim Investigational Site
Lyndhurst, Ohio, United States
1160.26.0275 Boehringer Ingelheim Investigational Site
Sandusky, Ohio, United States
1160.26.0103 Boehringer Ingelheim Investigational Site
Westlake, Ohio, United States
United States, Oklahoma
1160.26.0155 Boehringer Ingelheim Investigational Site
Bartlesville, Oklahoma, United States
1160.26.0435 Boehringer Ingelheim Investigational Site
Tulsa, Oklahoma, United States
United States, Oregon
1160.26.0139 Boehringer Ingelheim Investigational Site
Corvallis, Oregon, United States
1160.26.0325 Boehringer Ingelheim Investigational Site
Eugene, Oregon, United States
1160.26.0078 Boehringer Ingelheim Investigational Site
Hillsboro, Oregon, United States
1160.26.0245 Boehringer Ingelheim Investigational Site
Portland, Oregon, United States
1160.26.0133 Boehringer Ingelheim Investigational Site
Springfield, Oregon, United States
United States, Pennsylvania
1160.26.0301 Boehringer Ingelheim Investigational Site
Allentown, Pennsylvania, United States
1160.26.0454 Boehringer Ingelheim Investigational Site
Altoona, Pennsylvania, United States
1160.26.0295 Boehringer Ingelheim Investigational Site
Camp Hill, Pennsylvania, United States
1160.26.0294 Boehringer Ingelheim Investigational Site
Hershey, Pennsylvania, United States
1160.26.0369 Boehringer Ingelheim Investigational Site
Jenkintown, Pennsylvania, United States
1160.26.0303 Boehringer Ingelheim Investigational Site
Jersey Shore, Pennsylvania, United States
1160.26.0431 Boehringer Ingelheim Investigational Site
Lancaster, Pennsylvania, United States
1160.26.0168 Boehringer Ingelheim Investigational Site
Langhorne, Pennsylvania, United States
1160.26.0293 Boehringer Ingelheim Investigational Site
Meadowbrook, Pennsylvania, United States
1160.26.0025 Boehringer Ingelheim Investigational Site
Newton, Pennsylvania, United States
1160.26.0394 Boehringer Ingelheim Investigational Site
Norristown, Pennsylvania, United States
1160.26.0181 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
1160.26.0416 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
1160.26.0158 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
1160.26.0466 Boehringer Ingelheim Investigational Site
Pittsburgh, Pennsylvania, United States
1160.26.0344 Boehringer Ingelheim Investigational Site
Pittsburgh, Pennsylvania, United States
1160.26.0208 Boehringer Ingelheim Investigational Site
Sellersville, Pennsylvania, United States
1160.26.0465 Boehringer Ingelheim Investigational Site
Uniontown, Pennsylvania, United States
1160.26.0400 Boehringer Ingelheim Investigational Site
Upland, Pennsylvania, United States
1160.26.0032 Boehringer Ingelheim Investigational Site
Wynnewood, Pennsylvania, United States
1160.26.0067 Boehringer Ingelheim Investigational Site
Wyomissing, Pennsylvania, United States
United States, Rhode Island
1160.26.0212 Boehringer Ingelheim Investigational Site
Pawtucket, Rhode Island, United States
United States, South Carolina
1160.26.0007 Boehringer Ingelheim Investigational Site
Beaufort, South Carolina, United States
1160.26.0383 Boehringer Ingelheim Investigational Site
Charleston, South Carolina, United States
1160.26.0313 Boehringer Ingelheim Investigational Site
Greenville, South Carolina, United States
1160.26.0450 Boehringer Ingelheim Investigational Site
Mt. Pleasant, South Carolina, United States
1160.26.0166 Boehringer Ingelheim Investigational Site
Spartanburg, South Carolina, United States
1160.26.0008 Boehringer Ingelheim Investigational Site
Summerville, South Carolina, United States
1160.26.0468 Boehringer Ingelheim Investigational Site
West Columbia, South Carolina, United States
United States, South Dakota
1160.26.0348 Boehringer Ingelheim Investigational Site
Rapid City, South Dakota, United States
United States, Tennessee
1160.26.0084 Boehringer Ingelheim Investigational Site
Chattanooga, Tennessee, United States
1160.26.0062 Boehringer Ingelheim Investigational Site
Germantown, Tennessee, United States
1160.26.0370 Boehringer Ingelheim Investigational Site
Johnson City, Tennessee, United States
1160.26.0323 Boehringer Ingelheim Investigational Site
Nashville, Tennessee, United States
1160.26.0395 Boehringer Ingelheim Investigational Site
Nashville, Tennessee, United States
1160.26.0474 Boehringer Ingelheim Investigational Site
Oak Ridge, Tennessee, United States
United States, Texas
1160.26.0410 Boehringer Ingelheim Investigational Site
Austin, Texas, United States
1160.26.0129 Boehringer Ingelheim Investigational Site
Austin, Texas, United States
1160.26.0156 Boehringer Ingelheim Investigational Site
Dallas, Texas, United States
1160.26.0444 Boehringer Ingelheim Investigational Site
Fort Worth, Texas, United States
1160.26.0315 Boehringer Ingelheim Investigational Site
Fort Worth, Texas, United States
1160.26.0447 Boehringer Ingelheim Investigational Site
Houston, Texas, United States
1160.26.0483 Boehringer Ingelheim Investigational Site
Killeen, Texas, United States
1160.26.0335 Boehringer Ingelheim Investigational Site
Lubbock, Texas, United States
1160.26.0230 Boehringer Ingelheim Investigational Site
McKinney, Texas, United States
1160.26.0467 Boehringer Ingelheim Investigational Site
Plano, Texas, United States
1160.26.0013 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
1160.26.0269 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
1160.26.0307 Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
1160.26.0285 Boehringer Ingelheim Investigational Site
San Marcos, Texas, United States
1160.26.0367 Boehringer Ingelheim Investigational Site
Tyler, Texas, United States
1160.26.0215 Boehringer Ingelheim Investigational Site
Tyler, Texas, United States
United States, Virginia
1160.26.0195 Boehringer Ingelheim Investigational Site
Arlington, Virginia, United States
1160.26.0453 Boehringer Ingelheim Investigational Site
Charlottesville, Virginia, United States
1160.26.0053 Boehringer Ingelheim Investigational Site
Chesapeake, Virginia, United States
1160.26.0098 Boehringer Ingelheim Investigational Site
Danville, Virginia, United States
1160.26.0386 Boehringer Ingelheim Investigational Site
Falls Church, Virginia, United States
1160.26.0428 Boehringer Ingelheim Investigational Site
Fredericksburg, Virginia, United States
1160.26.0311 Boehringer Ingelheim Investigational Site
Harrisonburg, Virginia, United States
1160.26.0292 Boehringer Ingelheim Investigational Site
Newport News, Virginia, United States
1160.26.0224 Boehringer Ingelheim Investigational Site
Norfolk, Virginia, United States
1160.26.0220 Boehringer Ingelheim Investigational Site
Salem, Virginia, United States
1160.26.0317 Boehringer Ingelheim Investigational Site
Winchester, Virginia, United States
United States, Washington
1160.26.0287 Boehringer Ingelheim Investigational Site
Bellevue, Washington, United States
1160.26.0050 Boehringer Ingelheim Investigational Site
Bellingham, Washington, United States
1160.26.0040 Boehringer Ingelheim Investigational Site
Burien, Washington, United States
1160.26.0298 Boehringer Ingelheim Investigational Site
Olympia, Washington, United States
1160.26.0250 Boehringer Ingelheim Investigational Site
Spokane, Washington, United States
1160.26.0256 Boehringer Ingelheim Investigational Site
Tacoma, Washington, United States
1160.26.0024 Boehringer Ingelheim Investigational Site
Wenatchee, Washington, United States
United States, West Virginia
1160.26.0193 Boehringer Ingelheim Investigational Site
Charleston, West Virginia, United States
1160.26.0169 Boehringer Ingelheim Investigational Site
Clarksburg, West Virginia, United States
1160.26.0365 Boehringer Ingelheim Investigational Site
Huntington, West Virginia, United States
United States, Wisconsin
1160.26.0072 Boehringer Ingelheim Investigational Site
Elkhorn, Wisconsin, United States
1160.26.0234 Boehringer Ingelheim Investigational Site
Green Bay, Wisconsin, United States
1160.26.0099 Boehringer Ingelheim Investigational Site
Madison, Wisconsin, United States
1160.26.0242 Boehringer Ingelheim Investigational Site
Madison, Wisconsin, United States
1160.26.0359 Boehringer Ingelheim Investigational Site
Marshfield, Wisconsin, United States
1160.26.0461 Boehringer Ingelheim Investigational Site
Milwaukee, Wisconsin, United States
Argentina
1160.26.0523 Boehringer Ingelheim Investigational Site
Bahía Blanca, Argentina
1160.26.0533 Boehringer Ingelheim Investigational Site
Capital Federal, Argentina
1160.26.0524 Boehringer Ingelheim Investigational Site
Capital Federal, Argentina
1160.26.0526 Boehringer Ingelheim Investigational Site
Cipolletti, Argentina
1160.26.0529 Boehringer Ingelheim Investigational Site
Coronel Suárez, Argentina
1160.26.0531 Boehringer Ingelheim Investigational Site
Córdoba, Argentina
1160.26.0530 Boehringer Ingelheim Investigational Site
La Plata, Argentina
1160.26.0532 Boehringer Ingelheim Investigational Site
Mar del Plata, Argentina
1160.26.0527 Boehringer Ingelheim Investigational Site
Mar del Plata, Argentina
1160.26.0525 Boehringer Ingelheim Investigational Site
Quilmes, Argentina
1160.26.0521 Boehringer Ingelheim Investigational Site
Rosario, Argentina
1160.26.0528 Boehringer Ingelheim Investigational Site
Salta, Argentina
1160.26.0522 Boehringer Ingelheim Investigational Site
Santa Fe, Argentina
Australia, New South Wales
1160.26.0508 Boehringer Ingelheim Investigational Site
Coffs Harbour, New South Wales, Australia
1160.26.0510 Boehringer Ingelheim Investigational Site
Gosford, New South Wales, Australia
Australia, Queensland
1160.26.0505 Boehringer Ingelheim Investigational Site
Herston, Queensland, Australia
1160.26.0506 Boehringer Ingelheim Investigational Site
Milton, Queensland, Australia
Australia, South Australia
1160.26.0509 Boehringer Ingelheim Investigational Site
Ashford, South Australia, Australia
Australia, Tasmania
1160.26.0507 Boehringer Ingelheim Investigational Site
Launceston, Tasmania, Australia
Australia, Victoria
1160.26.0504 Boehringer Ingelheim Investigational Site
Box Hill, Victoria, Australia
1160.26.0501 Boehringer Ingelheim Investigational Site
Geelong, Victoria, Australia
1160.26.0502 Boehringer Ingelheim Investigational Site
Parkville, Victoria, Australia
1160.26.0503 Boehringer Ingelheim Investigational Site
Prahran, Victoria, Australia
Austria
1160.26.0543 Boehringer Ingelheim Investigational Site
Graz, Austria
1160.26.0549 Boehringer Ingelheim Investigational Site
Linz, Austria
1160.26.0546 Boehringer Ingelheim Investigational Site
Wels, Austria
1160.26.0544 Boehringer Ingelheim Investigational Site
Wien, Austria
1160.26.0545 Boehringer Ingelheim Investigational Site
Wien, Austria
1160.26.0541 Boehringer Ingelheim Investigational Site
Wien, Austria
1160.26.0547 Boehringer Ingelheim Investigational Site
Wien, Austria
1160.26.0548 Boehringer Ingelheim Investigational Site
Wien, Austria
1160.26.0542 Boehringer Ingelheim Investigational Site
Wien, Austria
1160.26.0550 Boehringer Ingelheim Investigational Site
Wr. Neustadt, Austria
Belgium
1160.26.0564 Boehringer Ingelheim Investigational Site
Aalst, Belgium
1160.26.0575 Boehringer Ingelheim Investigational Site
Antwerpen, Belgium
1160.26.0573 Boehringer Ingelheim Investigational Site
Antwerpen, Belgium
1160.26.0572 Boehringer Ingelheim Investigational Site
Brasschaat, Belgium
1160.26.0577 Boehringer Ingelheim Investigational Site
Brugge, Belgium
1160.26.0571 Boehringer Ingelheim Investigational Site
Brussels, Belgium
1160.26.0581 Boehringer Ingelheim Investigational Site
Bruxelles, Belgium
1160.26.0585 Boehringer Ingelheim Investigational Site
Bruxelles, Belgium
1160.26.0586 Boehringer Ingelheim Investigational Site
Bruxelles, Belgium
1160.26.0563 Boehringer Ingelheim Investigational Site
Edegem, Belgium
1160.26.0578 Boehringer Ingelheim Investigational Site
Genk, Belgium
1160.26.0587 Boehringer Ingelheim Investigational Site
Genk, Belgium
1160.26.0574 Boehringer Ingelheim Investigational Site
Gent, Belgium
1160.26.0588 Boehringer Ingelheim Investigational Site
Gilly, Belgium
1160.26.0580 Boehringer Ingelheim Investigational Site
Haine-St.-Paul, Belgium
1160.26.0568 Boehringer Ingelheim Investigational Site
Hasselt, Belgium
1160.26.0569 Boehringer Ingelheim Investigational Site
Kortrijk, Belgium
1160.26.0561 Boehringer Ingelheim Investigational Site
Leuven, Belgium
1160.26.0579 Boehringer Ingelheim Investigational Site
Liège, Belgium
1160.26.0583 Boehringer Ingelheim Investigational Site
Liège, Belgium
1160.26.0589 Boehringer Ingelheim Investigational Site
Mol, Belgium
1160.26.0567 Boehringer Ingelheim Investigational Site
Oostende, Belgium
1160.26.0570 Boehringer Ingelheim Investigational Site
Roeselare, Belgium
1160.26.0566 Boehringer Ingelheim Investigational Site
Tienen, Belgium
1160.26.0562 Boehringer Ingelheim Investigational Site
Turnhout, Belgium
Brazil
1160.26.550648 Boehringer Ingelheim Investigational Site
Belo Horizonte, Brazil
1160.26.550654 Boehringer Ingelheim Investigational Site
Blumenau, Brazil
1160.26.550644 Boehringer Ingelheim Investigational Site
Campinas, Brazil
1160.26.550650 Boehringer Ingelheim Investigational Site
Curitiba, Brazil
1160.26.550651 Boehringer Ingelheim Investigational Site
Curitiba, Brazil
1160.26.550653 Boehringer Ingelheim Investigational Site
Curitiba, Brazil
1160.26.550652 Boehringer Ingelheim Investigational Site
Goiania, Brazil
1160.26.550645 Boehringer Ingelheim Investigational Site
Marília, Brazil
1160.26.550647 Boehringer Ingelheim Investigational Site
São José do Rio Preto, Brazil
1160.26.550646 Boehringer Ingelheim Investigational Site
São José do Rio Preto, Brazil
1160.26.550643 Boehringer Ingelheim Investigational Site
São Paulo, Brazil
1160.26.550642 Boehringer Ingelheim Investigational Site
São Paulo, Brazil
1160.26.550641 Boehringer Ingelheim Investigational Site
São Paulo, Brazil
1160.26.550649 Boehringer Ingelheim Investigational Site
Uberaba, Brazil
Bulgaria
1160.26.0620 Boehringer Ingelheim Investigational Site
Pleven, Bulgaria
1160.26.0618 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0613 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0611 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0615 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0616 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0617 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0612 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0614 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0625 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0622 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0623 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0624 Boehringer Ingelheim Investigational Site
Sofia, Bulgaria
1160.26.0626 Boehringer Ingelheim Investigational Site
Stara Zagora, Bulgaria
1160.26.0621 Boehringer Ingelheim Investigational Site
Varna, Bulgaria
Canada, Alberta
1160.26.0694 Boehringer Ingelheim Investigational Site
Calgary, Alberta, Canada
1160.26.0696 Boehringer Ingelheim Investigational Site
Calgary, Alberta, Canada
Canada, British Columbia
1160.26.0712 Boehringer Ingelheim Investigational Site
Coquitlam, British Columbia, Canada
1160.26.0680 Boehringer Ingelheim Investigational Site
Coquitlam, British Columbia, Canada
1160.26.0706 Boehringer Ingelheim Investigational Site
Kelowna, British Columbia, Canada
1160.26.0725 Boehringer Ingelheim Investigational Site
Nanaimo, British Columbia, Canada
1160.26.0691 Boehringer Ingelheim Investigational Site
New Westminster, British Columbia, Canada
1160.26.0714 Boehringer Ingelheim Investigational Site
Victoria, British Columbia, Canada
Canada, Manitoba
1160.26.0701 Boehringer Ingelheim Investigational Site
Portage la Prairie, Manitoba, Canada
1160.26.0698 Boehringer Ingelheim Investigational Site
Winnipeg, Manitoba, Canada
Canada, Newfoundland and Labrador
1160.26.0707 Boehringer Ingelheim Investigational Site
Bay Roberts, Newfoundland and Labrador, Canada
Canada, Nova Scotia
1160.26.0676 Boehringer Ingelheim Investigational Site
Antigonish, Nova Scotia, Canada
1160.26.0703 Boehringer Ingelheim Investigational Site
Halifax, Nova Scotia, Canada
Canada, Ontario
1160.26.0679 Boehringer Ingelheim Investigational Site
Ajax, Ontario, Canada
1160.26.0677 Boehringer Ingelheim Investigational Site
Brampton, Ontario, Canada
1160.26.0674 Boehringer Ingelheim Investigational Site
Burlington, Ontario, Canada
1160.26.0720 Boehringer Ingelheim Investigational Site
Cambridge, Ontario, Canada
1160.26.0702 Boehringer Ingelheim Investigational Site
Cambridge, Ontario, Canada
1160.26.0671 Clinical Research & Diagnostic Solutions Inc.
Etobicoke, Ontario, Canada
1160.26.0692 Boehringer Ingelheim Investigational Site
Grimsby, Ontario, Canada
1160.26.0685 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
1160.26.0697 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
1160.26.0721 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
1160.26.0719 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
1160.26.0710 Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
1160.26.0689 Boehringer Ingelheim Investigational Site
Kitchener, Ontario, Canada
1160.26.0695 Boehringer Ingelheim Investigational Site
Mississauga, Ontario, Canada
1160.26.0708 Boehringer Ingelheim Investigational Site
Mississauga, Ontario, Canada
1160.26.0724 Boehringer Ingelheim Investigational Site
Mississauga, Ontario, Canada
1160.26.0688 Boehringer Ingelheim Investigational Site
Newmarket, Ontario, Canada
1160.26.0672 Boehringer Ingelheim Investigational Site
Oshawa, Ontario, Canada
1160.26.0687 Boehringer Ingelheim Investigational Site
Ottawa, Ontario, Canada
1160.26.0723 Boehringer Ingelheim Investigational Site
Scarborough, Ontario, Canada
1160.26.0715 Boehringer Ingelheim Investigational Site
Sudbury, Ontario, Canada
1160.26.0690 Boehringer Ingelheim Investigational Site
Thunder Bay, Ontario, Canada
1160.26.0718 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
1160.26.0684 Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
1160.26.0711 Boehringer Ingelheim Investigational Site
Waterloo, Ontario, Canada
1160.26.0686 Boehringer Ingelheim Investigational Site
Windsor, Ontario, Canada
Canada, Quebec
1160.26.0693 Boehringer Ingelheim Investigational Site
Longueuil, Quebec, Canada
1160.26.0681 Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
1160.26.0683 Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
1160.26.0709 Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
1160.26.0716 Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
1160.26.0705 Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
1160.26.0717 Boehringer Ingelheim Investigational Site
Quebec City, Quebec, Canada
1160.26.0704 Boehringer Ingelheim Investigational Site
Saint Jerome, Quebec, Canada
1160.26.0699 Boehringer Ingelheim Investigational Site
St. Charles-Borromee, Quebec, Canada
1160.26.0713 Boehringer Ingelheim Investigational Site
St. George-de-Beauce, Quebec, Canada
1160.26.0675 Boehringer Ingelheim Investigational Site
St. Hyacinthe, Quebec, Canada
1160.26.0700 Boehringer Ingelheim Investigational Site
Ste-Foy, Quebec, Canada
1160.26.0682 Boehringer Ingelheim Investigational Site
Terrebonne (Lachenaie), Quebec, Canada
Canada, Saskatchewan
1160.26.0673 Boehringer Ingelheim Investigational Site
Saskatoon, Saskatchewan, Canada
1160.26.0678 Boehringer Ingelheim Investigational Site
Saskatoon, Saskatchewan, Canada
China
1160.26.0771 Boehringer Ingelheim Investigational Site
Beijing, China
1160.26.0772 Boehringer Ingelheim Investigational Site
Beijing, China
1160.26.0773 Boehringer Ingelheim Investigational Site
Beijing, China
1160.26.0783 Boehringer Ingelheim Investigational Site
Beijing, China
1160.26.0775 Boehringer Ingelheim Investigational Site
Beijing, China
1160.26.0774 Boehringer Ingelheim Investigational Site
Beijing, China
1160.26.0784 Boehringer Ingelheim Investigational Site
Hangzhou, China
1160.26.0776 Boehringer Ingelheim Investigational Site
Harbin, China
1160.26.0778 Boehringer Ingelheim Investigational Site
QingDao, China
1160.26.0781 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.26.0782 Boehringer Ingelheim Investigational Site
Shanghai, China
1160.26.0777 Boehringer Ingelheim Investigational Site
Shenyang, China
1160.26.0780 Boehringer Ingelheim Investigational Site
Shijiazhuang, China
Colombia
1160.26.0803 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
1160.26.0801 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
1160.26.0802 Boehringer Ingelheim Investigational Site
Bogotá, Colombia
Czech Republic
1160.26.0816 Boehringer Ingelheim Investigational Site
Brno, Czech Republic
1160.26.0815 Boehringer Ingelheim Investigational Site
Brno, Czech Republic
1160.26.0820 Boehringer Ingelheim Investigational Site
Ostrava 1, Czech Republic
1160.26.0818 Boehringer Ingelheim Investigational Site
Pardubice, Czech Republic
1160.26.0814 Boehringer Ingelheim Investigational Site
Plzen-Bory, Czech Republic
1160.26.0813 Boehringer Ingelheim Investigational Site
Pragha 9, Czech Republic
1160.26.0811 Boehringer Ingelheim Investigational Site
Prague 5, Czech Republic
1160.26.0812 Boehringer Ingelheim Investigational Site
Praha 6, Czech Republic
1160.26.0817 Boehringer Ingelheim Investigational Site
Pribram, Czech Republic
1160.26.0819 Boehringer Ingelheim Investigational Site
Usti nad Orlici, Czech Republic
Denmark
1160.26.0837 Boehringer Ingelheim Investigational Site
Aalborg, Denmark
1160.26.0835 Boehringer Ingelheim Investigational Site
Aarhus C, Denmark
1160.26.0838 Boehringer Ingelheim Investigational Site
Frederikssund, Denmark
1160.26.0833 Boehringer Ingelheim Investigational Site
Helsingør, Denmark
1160.26.0834 Boehringer Ingelheim Investigational Site
Herlev, Denmark
1160.26.0841 Boehringer Ingelheim Investigational Site
Horsens, Denmark
1160.26.0832 Boehringer Ingelheim Investigational Site
Hvidovre, Denmark
1160.26.0840 Boehringer Ingelheim Investigational Site
Køge, Denmark
1160.26.0831 Boehringer Ingelheim Investigational Site
Odense, Denmark
1160.26.0839 Boehringer Ingelheim Investigational Site
Roskilde, Denmark
1160.26.0836 Boehringer Ingelheim Investigational Site
Svendborg, Denmark
Finland
1160.26.0856 Boehringer Ingelheim Investigational Site
Espoo, Finland
1160.26.0851 Boehringer Ingelheim Investigational Site
HUS, Finland
1160.26.0859 Boehringer Ingelheim Investigational Site
Jyväskylä, Finland
1160.26.0855 Boehringer Ingelheim Investigational Site
Kuopio, Finland
1160.26.0857 Boehringer Ingelheim Investigational Site
Lappeenranta, Finland
1160.26.0854 Boehringer Ingelheim Investigational Site
OYS, Finland
1160.26.0858 Boehringer Ingelheim Investigational Site
Pori, Finland
1160.26.0852 Boehringer Ingelheim Investigational Site
Tampere, Finland
1160.26.0853 Boehringer Ingelheim Investigational Site
Turku, Finland
France
1160.26.0875A Boehringer Ingelheim Investigational Site
ABBEVILLE cedex, France
1160.26.0882L Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882A Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882I Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882K Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0884A Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882G Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882E Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882D Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882C Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882B Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0882H Boehringer Ingelheim Investigational Site
Angers, France
1160.26.0887A Boehringer Ingelheim Investigational Site
Cholet, France
1160.26.0889A Boehringer Ingelheim Investigational Site
Gap, France
1160.26.0888A Boehringer Ingelheim Investigational Site
Grenoble, France
1160.26.0879C Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0879E Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0879F Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0881D Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0880A Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0881A Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0879B Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0879A Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0880G Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0879H Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0879G Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0880F Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0879S Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0880J Boehringer Ingelheim Investigational Site
Joue les Tours, France
1160.26.0880D Boehringer Ingelheim Investigational Site
Joué les Tours, France
1160.26.0880C Boehringer Ingelheim Investigational Site
Joué les Tours, France
1160.26.0880B Boehringer Ingelheim Investigational Site
Joué les Tours, France
1160.26.0880E Boehringer Ingelheim Investigational Site
Joué les Tours, France
1160.26.0874A Boehringer Ingelheim Investigational Site
Langres, France
1160.26.0874B Boehringer Ingelheim Investigational Site
Langres, France
1160.26.0871A Boehringer Ingelheim Investigational Site
Paris, France
1160.26.0873A Boehringer Ingelheim Investigational Site
TOULOUSE cedex, France
1160.26.0886A Boehringer Ingelheim Investigational Site
Tourcoing, France
1160.26.0872B Boehringer Ingelheim Investigational Site
Valenciennes, France
1160.26.0872A Boehringer Ingelheim Investigational Site
VALENCIENNES cedex, France
1160.26.0872C Boehringer Ingelheim Investigational Site
Valenciennes cedex, France
Germany
1160.26.0948 Boehringer Ingelheim Investigational Site
Berlin, Germany
1160.26.0932 Boehringer Ingelheim Investigational Site
Berlin, Germany
1160.26.0962 Boehringer Ingelheim Investigational Site
Berlin, Germany
1160.26.0940 Boehringer Ingelheim Investigational Site
Bochum, Germany
1160.26.0936 Boehringer Ingelheim Investigational Site
Coburg, Germany
1160.26.0968 Boehringer Ingelheim Investigational Site
Dachau, Germany
1160.26.0972 Boehringer Ingelheim Investigational Site
Dortmund, Germany
1160.26.0957 Boehringer Ingelheim Investigational Site
Duisburg, Germany
1160.26.0971 Boehringer Ingelheim Investigational Site
Erlangen, Germany
1160.26.0965 Boehringer Ingelheim Investigational Site
Eschweiler, Germany
1160.26.0934 Boehringer Ingelheim Investigational Site
Essen, Germany
1160.26.0931 Boehringer Ingelheim Investigational Site
Frankfurt/Main, Germany
1160.26.0943 Boehringer Ingelheim Investigational Site
Heidelberg, Germany
1160.26.0955 Boehringer Ingelheim Investigational Site
Kassel, Germany
1160.26.0963 Boehringer Ingelheim Investigational Site
Köln, Germany
1160.26.0946 Boehringer Ingelheim Investigational Site
Lahr, Germany
1160.26.0944 Boehringer Ingelheim Investigational Site
Limburg, Germany
1160.26.0951 Boehringer Ingelheim Investigational Site
Mainz, Germany
1160.26.0945 Boehringer Ingelheim Investigational Site
Mannheim, Germany
1160.26.0933 Boehringer Ingelheim Investigational Site
Mannheim, Germany
1160.26.0970 Boehringer Ingelheim Investigational Site
Mannheim, Germany
1160.26.0952 Boehringer Ingelheim Investigational Site
München, Germany
1160.26.0947 Boehringer Ingelheim Investigational Site
München, Germany
1160.26.0941 Boehringer Ingelheim Investigational Site
Papenburg, Germany
1160.26.0959 Boehringer Ingelheim Investigational Site
Suhl, Germany
1160.26.0937 Boehringer Ingelheim Investigational Site
Witten, Germany
1160.26.0966 Boehringer Ingelheim Investigational Site
Wuppertal, Germany
Greece
1160.26.0908 University Hospital of Alexandroupolis
Alexandroupolis, Greece
1160.26.0901 General Hospital "Alexandra", Therapeutic Clinic UOA
Athens, Greece
1160.26.0907 "Pammakaristos" Hospital of Athens
Athens, Greece
1160.26.0906 General Hospital ";Evangelismos"
Athens, Greece
1160.26.0915 "Hippokratio" Hospital of Athens
Athens, Greece
1160.26.0914 2nd IKA Hospital, Thessaloniki
Kalamaria-Thessaloniki, Greece
1160.26.0904 General Hospital of Larissa
Larissa, Greece
1160.26.0913 University Hospital of Larissa
Larissa, Greece
1160.26.0912 General Hospital of Leivadia
Leivadia, Greece
1160.26.0902 General Hospital " Papageorgiou"
Thessaloniki, Greece
1160.26.0910 General Hospital of Thiva
Thiva, Greece
1160.26.0903 General Hospital of Trikala
Trikala, Greece
1160.26.0905 Boehringer Ingelheim Investigational Site
Voula - Athens, Greece
Hong Kong
1160.26.1001 Boehringer Ingelheim Investigational Site
Hong Kong, Hong Kong
1160.26.1002 Boehringer Ingelheim Investigational Site
Hong Kong, Hong Kong
1160.26.1003 Boehringer Ingelheim Investigational Site
Kowloon, Hong Kong
1160.26.1004 Boehringer Ingelheim Investigational Site
Kowloon, Hong Kong
Hungary
1160.26.1011 Boehringer Ingelheim Investigational Site
Budapest, Hungary
1160.26.1012 Boehringer Ingelheim Investigational Site
Budapest, Hungary
1160.26.1013 Boehringer Ingelheim Investigational Site
Budapest, Hungary
1160.26.1014 Boehringer Ingelheim Investigational Site
Budapest, Hungary
1160.26.1015 Boehringer Ingelheim Investigational Site
Budapest, Hungary
1160.26.1016 Boehringer Ingelheim Investigational Site
Budapest, Hungary
1160.26.1020 Boehringer Ingelheim Investigational Site
Gyongyos, Hungary
1160.26.1017 Boehringer Ingelheim Investigational Site
Komarom, Hungary
1160.26.1018 Boehringer Ingelheim Investigational Site
Pecs, Hungary
1160.26.1019 Boehringer Ingelheim Investigational Site
Veszprem, Hungary
India
1160.26.1056 Boehringer Ingelheim Investigational Site
Ahmedabad, India
1160.26.1057 Boehringer Ingelheim Investigational Site
Ahmedabad, India
1160.26.1065 Boehringer Ingelheim Investigational Site
Bangalore, India
1160.26.1064 Boehringer Ingelheim Investigational Site
Bangalore, India
1160.26.1071 Boehringer Ingelheim Investigational Site
Bikaner, India
1160.26.1066 Boehringer Ingelheim Investigational Site
Chennai, India
1160.26.1069 Boehringer Ingelheim Investigational Site
Coimbatore, India
1160.26.1062 Boehringer Ingelheim Investigational Site
Hyderabad, India
1160.26.1058 Boehringer Ingelheim Investigational Site
Indore, India
1160.26.1073 Boehringer Ingelheim Investigational Site
Jaipur, India
1160.26.1053 Boehringer Ingelheim Investigational Site
Jaipur, India
1160.26.1067 Boehringer Ingelheim Investigational Site
Kerala, India
1160.26.1068 Boehringer Ingelheim Investigational Site
Kottayam, India
1160.26.1055 Boehringer Ingelheim Investigational Site
Lucknow, India
1160.26.1051 Boehringer Ingelheim Investigational Site
Ludhiana, India
1160.26.1060 Boehringer Ingelheim Investigational Site
Mumbai, India
1160.26.1072 Boehringer Ingelheim Investigational Site
Mysore, India
1160.26.1059 Boehringer Ingelheim Investigational Site
Nagpur, India
1160.26.1052 Boehringer Ingelheim Investigational Site
New Delhi, India
1160.26.1070 Boehringer Ingelheim Investigational Site
Pune, India
Italy
1160.26.1169 Boehringer Ingelheim Investigational Site
Arezzo, Italy
1160.26.1172 Boehringer Ingelheim Investigational Site
Ascoli Piceno, Italy
1160.26.1180 Boehringer Ingelheim Investigational Site
Bentivoglio (BO), Italy
1160.26.1161 Boehringer Ingelheim Investigational Site
Bologna, Italy
1160.26.1163 Boehringer Ingelheim Investigational Site
Castelnuovo Garfagnana, Italy
1160.26.1178 Boehringer Ingelheim Investigational Site
Chieti, Italy
1160.26.1171 Boehringer Ingelheim Investigational Site
Colleferro, Italy
1160.26.1174 Boehringer Ingelheim Investigational Site
Cremona, Italy
1160.26.1167 Boehringer Ingelheim Investigational Site
Eboli, Italy
1160.26.1168 Boehringer Ingelheim Investigational Site
Isernia, Italy
1160.26.1162 Boehringer Ingelheim Investigational Site
Legnago, Italy
1160.26.1177 Boehringer Ingelheim Investigational Site
Mantova, Italy
1160.26.1165 Boehringer Ingelheim Investigational Site
Perugia San Sisto, Italy
1160.26.1175 Boehringer Ingelheim Investigational Site
Roma, Italy
1160.26.1181 Boehringer Ingelheim Investigational Site
San Bonifacio, Italy
1160.26.1173 Boehringer Ingelheim Investigational Site
San Daniele Del Friuli, Italy
1160.26.1176 Boehringer Ingelheim Investigational Site
Sassari, Italy
1160.26.1170 Boehringer Ingelheim Investigational Site
Sassari, Italy
Japan
1160.26.1204 Boehringer Ingelheim Investigational Site
Abeno-ku, Osaka, Osaka, Japan
1160.26.1209 Boehringer Ingelheim Investigational Site
Aki-gun, Hiroshima, Japan
1160.26.1193 Boehringer Ingelheim Investigational Site
Aoba-ku, Sendai, Miyagi, Japan
1160.26.1225 Boehringer Ingelheim Investigational Site
Chuo-ku, Fukuoka, Fukuoka, Japan
1160.26.1211 Boehringer Ingelheim Investigational Site
Chuo-ku, Fukuoka, Fukuoka, Japan
1160.26.1221 Boehringer Ingelheim Investigational Site
Chuo-ku, Kobe, Hyogo, Japan
1160.26.1219 Boehringer Ingelheim Investigational Site
Chuo-ku, Osaka, Osaka, Japan
1160.26.1229 Boehringer Ingelheim Investigational Site
Fujioka-shi , Gunma-ken, Japan
1160.26.1232 Boehringer Ingelheim Investigational Site
Fukushima-shi,Fukushima-ken, Japan
1160.26.1228 Boehringer Ingelheim Investigational Site
Higashimatsushimashi, Miyagi-ken, Japan
1160.26.1208 Boehringer Ingelheim Investigational Site
Himeji, Hyogo, Japan
1160.26.1214 Boehringer Ingelheim Investigational Site
Iida, Nagano, Japan
1160.26.1240 Boehringer Ingelheim Investigational Site
Isesaki-shi,Gunma, Japan
1160.26.1224 Boehringer Ingelheim Investigational Site
Iwakuni, Yamaguchi, Japan
1160.26.1194 Boehringer Ingelheim Investigational Site
Izumi-ku, Sendai, Miyagi, Japan
1160.26.1241 Boehringer Ingelheim Investigational Site
Kamigyo-ku, Kyoto, Japan
1160.26.1220 Boehringer Ingelheim Investigational Site
Kawachinagano, Osaka, Japan
1160.26.1203 Boehringer Ingelheim Investigational Site
Kita-ku, Osaka, Osaka, Japan
1160.26.1207 Boehringer Ingelheim Investigational Site
Kita-ku, Sakai, Osaka, Japan
1160.26.1231 Boehringer Ingelheim Investigational Site
Komatsu-shi,Ishikawa -ken, Japan
1160.26.1233 Boehringer Ingelheim Investigational Site
Kyoto-shi,Kyoto, Japan
1160.26.1242 Boehringer Ingelheim Investigational Site
Matsumoto, Nagano, Japan
1160.26.1210 Boehringer Ingelheim Investigational Site
Minami-ku, Fukuoka, Fukuoka, Japan
1160.26.1218 Boehringer Ingelheim Investigational Site
Minato, Tokyo, Japan
1160.26.1201 Boehringer Ingelheim Investigational Site
Minato-ku, Nagoya, Aichi, Japan
1160.26.1200 Boehringer Ingelheim Investigational Site
Minato-ku, Nagoya, Aichi, Japan
1160.26.1216 Boehringer Ingelheim Investigational Site
Narashino, Chiba, Japan
1160.26.1237 Boehringer Ingelheim Investigational Site
Nishinomiya-shi,Hyogo, Japan
1160.26.1223 Boehringer Ingelheim Investigational Site
Okayama, Okayama, Japan
1160.26.1197 Boehringer Ingelheim Investigational Site
Oota, Tokyo, Japan
1160.26.1212 Boehringer Ingelheim Investigational Site
Otaru, Hokkaido, Japan
1160.26.1230 Boehringer Ingelheim Investigational Site
Sagamihara, Kanagawa-ken, Japan
1160.26.1238 Boehringer Ingelheim Investigational Site
Sapporo-shi,Hokkai-do, Japan
1160.26.1217 Boehringer Ingelheim Investigational Site
Shibuya, Tokyo, Japan
1160.26.1196 Boehringer Ingelheim Investigational Site
Shinjuku, Tokyo, Japan
1160.26.1191 Boehringer Ingelheim Investigational Site
Shiroishi-ku, Sapporo, Hokkaido, Japan
1160.26.1192 Boehringer Ingelheim Investigational Site
Shiroishi-ku, Sapporo, Hokkaido, Japan
1160.26.1206 Boehringer Ingelheim Investigational Site
Suita, Osaka, Japan
1160.26.1235 Boehringer Ingelheim Investigational Site
Suita-shi, Osaka, Japan
1160.26.1236 Boehringer Ingelheim Investigational Site
Suita-shi, Osaka, Japan
1160.26.1205 Boehringer Ingelheim Investigational Site
Sumiyoshi-ku, Osaka, Osaka, Japan
1160.26.1234 Boehringer Ingelheim Investigational Site
Takatsuki-shi,Osaka, Japan
1160.26.1215 Boehringer Ingelheim Investigational Site
Tokorozawa, Saitama, Japan
1160.26.1198 Boehringer Ingelheim Investigational Site
Totsuka-ku, Yokohama, Kanagawa, Japan
1160.26.1195 Boehringer Ingelheim Investigational Site
Tsuchiura, Ibaragi, Japan
1160.26.1199 Boehringer Ingelheim Investigational Site
Ueda, Nagano, Japan
1160.26.1222 Boehringer Ingelheim Investigational Site
Wakayama, Wakayama, Japan
1160.26.1227 Boehringer Ingelheim Investigational Site
Yanagawa, Fukuoka, Japan
1160.26.1243 Boehringer Ingelheim Investigational Site
Yao, Osaka, Japan
Korea, Republic of
1160.26.1585 Boehringer Ingelheim Investigational Site
Busan, Korea, Republic of
1160.26.1586 Boehringer Ingelheim Investigational Site
Chungchungnam-Do, Korea, Republic of
1160.26.1591 Boehringer Ingelheim Investigational Site
Daegu, Korea, Republic of
1160.26.1584 Boehringer Ingelheim Investigational Site
Daegu, Korea, Republic of
1160.26.1590 Boehringer Ingelheim Investigational Site
Gwangju, Korea, Republic of
1160.26.1581 Boehringer Ingelheim Investigational Site
Incheon, Korea, Republic of
1160.26.1588 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.26.1589 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.26.1583 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.26.1582 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.26.1592 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
1160.26.1593 Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
Malaysia
1160.26.1297 Boehringer Ingelheim Investigational Site
Kajang,Selangor, Malaysia
1160.26.1291 Boehringer Ingelheim Investigational Site
Kuala Lumpur, Malaysia
1160.26.1292 Boehringer Ingelheim Investigational Site
Kuala Lumpur, Malaysia
1160.26.1294 Boehringer Ingelheim Investigational Site
Kuala Lumpur, Malaysia
1160.26.1293 Boehringer Ingelheim Investigational Site
Kuching, Malaysia
1160.26.1296 Boehringer Ingelheim Investigational Site
Penang, Malaysia
1160.26.1295 Boehringer Ingelheim Investigational Site
Penang, Malaysia
Mexico
1160.26.1318 Hospital General "Dr. Santiago Ramón y Cajal
Durango, Mexico
1160.26.1311 Hospital Mexico-Americano
Guadalajara, Mexico
1160.26.1317 hOSPITAL bERNARDETTE
Guadalajara, Mexico
1160.26.1319 Instituto Nacional de Cardiologia
Mexico, Mexico
1160.26.1312 Hospital de Jesus
Mexico, Mexico
1160.26.1314 Hospital 1o. de Octubre
México, Mexico
1160.26.1313 Hosp. Angeles Centro Medico del Potosi
San Luis Potosí, Mexico
1160.26.1322 Hospital Central "Dr. Ignacio Morones Prieto"
San Luis Potosí, Mexico
Netherlands
1160.26.1344 Boehringer Ingelheim Investigational Site
Almelo, Netherlands
1160.26.1331 Boehringer Ingelheim Investigational Site
Amsterdam, Netherlands
1160.26.1336 Boehringer Ingelheim Investigational Site
Apeldoorn, Netherlands
1160.26.1332 Boehringer Ingelheim Investigational Site
Breda, Netherlands
1160.26.1337 Boehringer Ingelheim Investigational Site
Den Bosch, Netherlands
1160.26.1349 Boehringer Ingelheim Investigational Site
Den Helder, Netherlands
1160.26.1345 Boehringer Ingelheim Investigational Site
Deventer, Netherlands
1160.26.1360 Boehringer Ingelheim Investigational Site
Dirksland, Netherlands
1160.26.1348 Boehringer Ingelheim Investigational Site
Dordrecht, Netherlands
1160.26.1340 Boehringer Ingelheim Investigational Site
Ede, Netherlands
1160.26.1358 Boehringer Ingelheim Investigational Site
Eindhoven, Netherlands
1160.26.1338 Boehringer Ingelheim Investigational Site
Enschede, Netherlands
1160.26.1343 Boehringer Ingelheim Investigational Site
Goes, Netherlands
1160.26.1347 Boehringer Ingelheim Investigational Site
Gorinchem, Netherlands
1160.26.1355 Boehringer Ingelheim Investigational Site
Groningen, Netherlands
1160.26.1333 Boehringer Ingelheim Investigational Site
Groningen, Netherlands
1160.26.1361 Boehringer Ingelheim Investigational Site
Heerlen, Netherlands
1160.26.1339 Boehringer Ingelheim Investigational Site
Hengelo, Netherlands
1160.26.1346 Boehringer Ingelheim Investigational Site
Hilversum, Netherlands
1160.26.1356 Boehringer Ingelheim Investigational Site
Hoorn, Netherlands
1160.26.1359 Boehringer Ingelheim Investigational Site
Maastricht, Netherlands
1160.26.1341 Boehringer Ingelheim Investigational Site
Meppel, Netherlands
1160.26.1354 Boehringer Ingelheim Investigational Site
Rotterdam, Netherlands
1160.26.1351 Boehringer Ingelheim Investigational Site
Sneek, Netherlands
1160.26.1334 Boehringer Ingelheim Investigational Site
Spiijkenisse, Netherlands
1160.26.1335 Boehringer Ingelheim Investigational Site
Terneuzen, Netherlands
1160.26.1353 Boehringer Ingelheim Investigational Site
Tiel, Netherlands
1160.26.1352 Boehringer Ingelheim Investigational Site
Tilburg, Netherlands
1160.26.1350 Boehringer Ingelheim Investigational Site
Veldhoven, Netherlands
1160.26.1342 Boehringer Ingelheim Investigational Site
Velp, Netherlands
1160.26.1357 Boehringer Ingelheim Investigational Site
Venlo, Netherlands
Norway
1160.26.1396 Boehringer Ingelheim Investigational Site
Gjøvik, Norway
1160.26.1393 Boehringer Ingelheim Investigational Site
Moss, Norway
1160.26.1395 Boehringer Ingelheim Investigational Site
Nordbyhagen, Norway
1160.26.1392 Boehringer Ingelheim Investigational Site
Oslo, Norway
1160.26.1397 Boehringer Ingelheim Investigational Site
Oslo, Norway
1160.26.1391 Boehringer Ingelheim Investigational Site
Oslo, Norway
1160.26.1394 Boehringer Ingelheim Investigational Site
RUD, Norway
Peru
1160.26.1415 Hospital Alberto Sabogal
Bella Vista, Peru
1160.26.1411 Clinica San Felipe
Jesús María, Peru
1160.26.1412 Clínica Anglo Americana
San Isidro, Peru
1160.26.1413 Hospital Cayetano Heredia
San Martín de Porres, Peru
1160.26.1414 Clínica Vesalio
Urbanización Sto Tomas de San Borja, Peru
Philippines
1160.26.1421 Philippine General Hospital
Manila, Philippines
1160.26.1422 Manila Doctors Hospital
Manila, Philippines
1160.26.1424 The Medical City
Pasig City, Philippines
1160.26.1423 Philippine Heart Center
Quezon City, Philippines
1160.26.1425 St Lukes Medical Center
Quezon City, Philippines
Poland
1160.26.1438 Boehringer Ingelheim Investigational Site
Gdynia, Poland
1160.26.1436 Boehringer Ingelheim Investigational Site
Gdynia, Poland
1160.26.1437 Boehringer Ingelheim Investigational Site
Gdynia Redlowo, Poland
1160.26.1435 Boehringer Ingelheim Investigational Site
Katowice, Poland
1160.26.1439 Boehringer Ingelheim Investigational Site
Krakow, Poland
1160.26.1440 Boehringer Ingelheim Investigational Site
Krakow, Poland
1160.26.1433 Boehringer Ingelheim Investigational Site
Pulawy, Poland
1160.26.1431 Boehringer Ingelheim Investigational Site
Warsaw, Poland
1160.26.1432 Boehringer Ingelheim Investigational Site
Warsaw, Poland
1160.26.1434 Boehringer Ingelheim Investigational Site
Zabrze, Poland
Portugal
1160.26.1456 Boehringer Ingelheim Investigational Site
Amadora, Portugal
1160.26.1451 Boehringer Ingelheim Investigational Site
Carnaxide, Portugal
1160.26.1459 Boehringer Ingelheim Investigational Site
Coimbra, Portugal
1160.26.1454 Boehringer Ingelheim Investigational Site
Coimbra, Portugal
1160.26.1457 Boehringer Ingelheim Investigational Site
Covilhã, Portugal
1160.26.1453 Boehringer Ingelheim Investigational Site
Lisboa, Portugal
1160.26.1458 Boehringer Ingelheim Investigational Site
Lisboa, Portugal
1160.26.1455 Boehringer Ingelheim Investigational Site
Porto, Portugal
1160.26.1452 Boehringer Ingelheim Investigational Site
Setúbal, Portugal
Romania
1160.26.1471 Boehringer Ingelheim Investigational Site
Bucharest, Romania
1160.26.1472 Boehringer Ingelheim Investigational Site
Bucharest, Romania
1160.26.1478 Boehringer Ingelheim Investigational Site
Cluj Napoca, Romania
Russian Federation
1160.26.1501 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1502 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1509 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1504 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1505 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1511 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1507 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1508 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1503 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1510 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1506 Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
1160.26.1512 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
1160.26.1513 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
1160.26.1514 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
1160.26.1515 Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
Singapore
1160.26.1531 Boehringer Ingelheim Investigational Site
Singapore, Singapore
1160.26.1532 Boehringer Ingelheim Investigational Site
Singapore, Singapore
Slovakia
1160.26.1548 Boehringer Ingelheim Investigational Site
Banska Bystrica, Slovakia
1160.26.1542 Boehringer Ingelheim Investigational Site
Bratislava, Slovakia
1160.26.1541 Boehringer Ingelheim Investigational Site
Bratislava, Slovakia
1160.26.1544 Boehringer Ingelheim Investigational Site
Bratislava, Slovakia
1160.26.1543 Boehringer Ingelheim Investigational Site
Bratislava, Slovakia
1160.26.1546 Boehringer Ingelheim Investigational Site
Bratislava, Slovakia
1160.26.1545 Boehringer Ingelheim Investigational Site
Bratislava, Slovakia
1160.26.1549 Boehringer Ingelheim Investigational Site
Kosice, Slovakia
1160.26.1550 Boehringer Ingelheim Investigational Site
Kosice, Slovakia
1160.26.1547 Boehringer Ingelheim Investigational Site
Zilina, Slovakia
South Africa
1160.26.1562 Boehringer Ingelheim Investigational Site
Bloemfontein, South Africa
1160.26.1569 Boehringer Ingelheim Investigational Site
Boksburg, South Africa
1160.26.1561 Boehringer Ingelheim Investigational Site
Cape Town, South Africa
1160.26.1567 Boehringer Ingelheim Investigational Site
Johannesburg, South Africa
1160.26.1564 Boehringer Ingelheim Investigational Site
Johannesburg, South Africa
1160.26.1568 Boehringer Ingelheim Investigational Site
Johannesburg, South Africa
1160.26.1566 Boehringer Ingelheim Investigational Site
Pretoria, South Africa
1160.26.1563 Boehringer Ingelheim Investigational Site
Randburg, South Africa
1160.26.1565 Boehringer Ingelheim Investigational Site
Somerset West, South Africa
Spain
1160.26.1601 Boehringer Ingelheim Investigational Site
Barcelona, Spain
1160.26.1606 Boehringer Ingelheim Investigational Site
Cadiz, Spain
1160.26.1607 Boehringer Ingelheim Investigational Site
Fuenlabrada (Madrid), Spain
1160.26.1604 Boehringer Ingelheim Investigational Site
Leganés, Madrid, Spain
1160.26.1603 Boehringer Ingelheim Investigational Site
Madrid, Spain
1160.26.1608 Boehringer Ingelheim Investigational Site
Madrid, Spain
1160.26.1609 Boehringer Ingelheim Investigational Site
Madrid-San Lorenzo del Escorial, Spain
1160.26.1605 Boehringer Ingelheim Investigational Site
Móstoles (Madrid), Spain
1160.26.1602 Boehringer Ingelheim Investigational Site
Sabadell, Spain
Sweden
1160.26.1633 Sahlgrenska Sjukhuset
Göteboerg, Sweden
1160.26.1629 AVK-mott, Spec.M1, Länssjukhuset Ryhov
Jönköping, Sweden
1160.26.1631 Universitetssjukhuset i Linköping
Linköping, Sweden
1160.26.1627 Hjärtmott. ING 35, Malmö Universitetssjukhus MAS
Malmö, Sweden
1160.26.1625 Hjärtmott./Medicinkliniken, Vrinnevisjukhuset
Norrköping, Sweden
1160.26.1628 Rådhusg. 29, Lars Mörlids Läkarmottagning
Nässjö, Sweden
1160.26.1626 Hjärtkärllaboratoriet, Danderyds Sjukhus AB
Stockholm, Sweden
1160.26.1632 Capio S:t Görans Sjukhus
Stockholm, Sweden
1160.26.1634 Södersjukhuset
Stockholm, Sweden
1160.26.1624 Klin. forskningscentrum, Norrlands Universitetssjukhus
Umeå, Sweden
1160.26.1621 Kardiologiska kliniken, Akademiska Sjukhuset
Uppsala, Sweden
1160.26.1635 UCR/Uppsala
Uppsala, Sweden
1160.26.1622 Hjärtmottagningen, Centrallasarettet
Västerås, Sweden
1160.26.1623 Kardiologiska kliniken, Universitetssjukhuset
Örebro, Sweden
Switzerland
1160.26.1652 Boehringer Ingelheim Investigational Site
Basel, Switzerland
1160.26.1655 Boehringer Ingelheim Investigational Site
Bellinzona, Switzerland
1160.26.1651 Boehringer Ingelheim Investigational Site
Bern, Switzerland
1160.26.1654 Boehringer Ingelheim Investigational Site
Lugano, Switzerland
Taiwan
1160.26.1680 Boehringer Ingelheim Investigational Site
Changhua County, Taiwan
1160.26.1683 Boehringer Ingelheim Investigational Site
Hualien, Taiwan
1160.26.1682 Boehringer Ingelheim Investigational Site
Kaohsiung, Taiwan
1160.26.1679 China Medical University Hospital
Taichung, Taiwan
1160.26.1681 Boehringer Ingelheim Investigational Site
Tainan, Taiwan
1160.26.1672 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.26.1675 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.26.1673 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.26.1674 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.26.1677 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.26.1671 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.26.1676 Boehringer Ingelheim Investigational Site
Taipei, Taiwan
1160.26.1678 Boehringer Ingelheim Investigational Site
Taoyuan, Taiwan
Thailand
1160.26.1701 Boehringer Ingelheim Investigational Site
Bangkok, Thailand
1160.26.1702 Boehringer Ingelheim Investigational Site
Bangkok, Thailand
1160.26.1703 Boehringer Ingelheim Investigational Site
Chiangmai, Thailand
1160.26.1704 Boehringer Ingelheim Investigational Site
Khon Kaen, Thailand
1160.26.1705 Boehringer Ingelheim Investigational Site
Muang Nakhonratchasima, Thailand
Turkey
1160.26.1715 Boehringer Ingelheim Investigational Site
Adana, Turkey
1160.26.1711 Boehringer Ingelheim Investigational Site
Ankara, Turkey
1160.26.1713 Gazi Universitesi Tip Fakultesi Kardiyoloji Abd
Ankara, Turkey
1160.26.1714 Dokuz Eylul Universitesi Tip Fakultesi
Izmir, Turkey
Ukraine
1160.26.1727 Boehringer Ingelheim Investigational Site
Dnyepropetrovsk, Ukraine
1160.26.1726 Boehringer Ingelheim Investigational Site
Kharkiv, Ukraine
1160.26.1725 Boehringer Ingelheim Investigational Site
Kharkov, Ukraine
1160.26.1724 Boehringer Ingelheim Investigational Site
Kharkov, Ukraine
1160.26.1730 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
1160.26.1722 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
1160.26.1721 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
1160.26.1723 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
1160.26.1731 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
1160.26.1728 Boehringer Ingelheim Investigational Site
Kiev, Ukraine
1160.26.1729 Boehringer Ingelheim Investigational Site
Lvov, Ukraine
United Kingdom
1160.26.1744 Boehringer Ingelheim Investigational Site
Birmingham, United Kingdom
1160.26.1746 Boehringer Ingelheim Investigational Site
Chertsey, United Kingdom
1160.26.1747 Boehringer Ingelheim Investigational Site
Glasgow, United Kingdom
1160.26.1750 Boehringer Ingelheim Investigational Site
Harrow, United Kingdom
1160.26.1753 Boehringer Ingelheim Investigational Site
Hull, United Kingdom
1160.26.1755 Boehringer Ingelheim Investigational Site
Kirkcaldy, Fife, United Kingdom
1160.26.1756 Boehringer Ingelheim Investigational Site
London, United Kingdom
1160.26.1741 Boehringer Ingelheim Investigational Site
London, United Kingdom
1160.26.1749 Boehringer Ingelheim Investigational Site
Londonderry, United Kingdom
1160.26.1742 Boehringer Ingelheim Investigational Site
Newcastle upon Tyne, United Kingdom
1160.26.1751 Boehringer Ingelheim Investigational Site
Newport, United Kingdom
1160.26.1752 Boehringer Ingelheim Investigational Site
Northampton, United Kingdom
1160.26.1745 Boehringer Ingelheim Investigational Site
Portadown, County Atrim, United Kingdom
1160.26.1743 Boehringer Ingelheim Investigational Site
Romford, Essex, United Kingdom
1160.26.1754 Boehringer Ingelheim Investigational Site
Stoke-On-Trent, United Kingdom
1160.26.1748 Boehringer Ingelheim Investigational Site
York, United Kingdom
Sponsors and Collaborators
Boehringer Ingelheim
Population Health Research Institute
Uppsala University
Investigators
Study Chair: Boehringer Ingelheim Boehringer Ingelheim
  More Information

Additional Information:
No publications provided by Boehringer Ingelheim

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Boehringer Ingelheim, Study Chair, Boehringer Ingelheim
ClinicalTrials.gov Identifier: NCT00262600     History of Changes
Other Study ID Numbers: 1160.26, 2005-003894-26
Study First Received: December 6, 2005
Results First Received: November 18, 2010
Last Updated: April 25, 2014
Health Authority: Argentina: A.N.M.A.T. (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica)
Australia: Responsilble Ethics Committee
Austria: Federal Office for Safety in Health Care
Belgium: Federal Agency for Medicines and Health Products, FAMHP
Brazil: National Health Surveillance Agency
Bulgaria: Bulgarian Drug Agency, BG-1504 Sofia
Canada: Health Canada
China: Food and Drug Administration
Colombia: INVIMA Instituto Nacional de Vigilancia de Medicamentos y Alimentos
Czech Republic: State Institute for Drug Control (SUKL), CZ-100 41 Prague 10
Denmark: Danish Medicines Agency
Finland: Finnish Medicines Agency
France: AFFSAPS
Germany: Federal Institute for Drugs and Medical Devices
Great Britain: MHRA
Greece: National Organization for Medicines (EOF) National Ethics Committee
Hong Kong: Department of Health
Hungary: National Institute of Pharmacy, H-1051 Budapest
India: Drug Control General of India
Israel: Ministry of Health
Italy: Comitato Etico Indipendente - BOLOGNA
Japan: Ministry of Health, Labor and Welfare
Korea, Republic of: KOREA Food and Drug Administration (KFDA)
Malaysia: Drug Control Authority
Mexico: Federal Commission for Sanitary Risks Protection
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Norway: Norwegian Medicines Agency (Statens Legemiddelverk)
Peru: General Directorate of Pharmaceuticals, Devices, and Drugs
Philippines: Bureau of Food and Drug
Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Portugal: INFARMED, National Authority of Medicines and Health Products, IP
Romania: National Medicines Agency, Bucharest
Russia: Ministry of Health of the Russian Federation
Singapore: Health Sciences Authority
Slovakia: SUKL (state institute for drug control), SK-825 08 Bratislava 26
South Africa: MCC
Spain: Agencia Española del Medicamento y Productos Sanitarios
Sweden: Medical Products Agency
Switzerland: Swissmedic
Taiwan: Department of Health, Executive Yuan, Taiwan
Thailand: Thai Food & Drug Administration
Turkey: Ministry of Health Central Ethics Committee
Ukraine: Ministry of Health Care of Ukraine (MoH of Ukraine)
United States: Food and Drug Administration

Additional relevant MeSH terms:
Atrial Fibrillation
Stroke
Cerebral Infarction
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Brain Infarction
Brain Ischemia
Dabigatran
Anticoagulants
Warfarin
Hematologic Agents
Therapeutic Uses
Pharmacologic Actions
Antithrombins
Serine Proteinase Inhibitors
Protease Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on August 26, 2014